D89.84
IgG4-related disease
Clinical Classification Guidelines
Inclusion Terms
- Immunoglobulin G4-related disease
Medical Intelligence & Overview
IgG4-related disease is a chronic condition marked by inflammation that can affect multiple organs in the body. It results from an abnormal immune response involving Immunoglobulin G4 (IgG4) antibodies. The disease can cause swelling and tissue damage, often mimicking other medical conditions. Recognizing and diagnosing IgG4-related disease is important because it may be treatable with appropriate medical care.
Causes & Symptoms
Clinical Causes: The exact cause of IgG4-related disease remains unknown. It is believed to involve an abnormal immune response where the body's immune system mistakenly attacks its own tissues. Genetic factors may play a role, with some individuals being more susceptible. Environmental triggers such as infections are also under investigation as potential contributors.
Key Symptoms: Swelling or mass formation in affected organs, which can be painless or tender. Organ dysfunction depending on the area involved, such as the pancreas, salivary glands, or lymph nodes. Fatigue and general malaise. Potential fever and weight loss in some cases. Symptoms vary widely based on organ involvement, which may include:
Diagnostic & Treatment
Diagnosis Path: Diagnosing IgG4-related disease involves a combination of clinical evaluation, laboratory tests, imaging studies, and tissue biopsies. Healthcare providers may look for elevated serum IgG4 levels, characteristic imaging findings, and histopathological features such as storiform fibrosis and infiltration of IgG4-positive plasma cells. Differential diagnosis is important to distinguish it from other conditions like cancer or autoimmune diseases.
Treatment Protocols: Treatment usually involves corticosteroids to reduce inflammation and suppress immune activity. In some cases, immunosuppressive medications or biologic agents like rituximab are used. Early diagnosis and management can prevent organ damage. Regular monitoring is essential to assess response to therapy and detect potential relapses.
Clinical Advice & FAQs
Billing Guidance
Is D89.84 a billable ICD-10 code?
Yes, D89.84 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.84?
Clinical documentation must specify the nature of IgG4-related disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference